The pharmacology of voltage-gated sodium channels in sensory neurones

Handbook of Experimental Pharmacology

Volumn 194, Issue , 2009, Pages 519-561

  Docherty, Reginald J ^a   Farmer, Clare E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesic; Antiarrhythmic; Anticonvulsant; Hyperalgesia; Local anaesthetic; Pain; Tetrodotoxin; Voltage gated sodium channel

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; A 803567; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; BENZOCAINE; CARBAMAZEPINE; CONOTOXIN; CROBENETINE; DISOPYRAMIDE; FLECAINIDE; IBUPROFEN; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; NEUROTOXIN; PHENYTOIN; PROCAINAMIDE; PROPAFENONE; QUINIDINE; RALFINAMIDE; SAXITOXIN; TOCAINIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL; SODIUM; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ANALGESIA; CHEMICAL STRUCTURE; DIABETIC NEUROPATHY; HEART ARRHYTHMIA; MODULATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENSORY DYSFUNCTION; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SODIUM CURRENT; STROKE; TREATMENT INDICATION; TRIGEMINUS NEURALGIA; ANIMAL; BINDING SITE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CHRONIC DISEASE; DRUG EFFECT; HUMAN; METABOLISM; SENSORY RECEPTOR; SYNDROME;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; BINDING SITES; CHRONIC DISEASE; HUMANS; ION CHANNEL GATING; MEMBRANE POTENTIALS; PAIN; SENSORY RECEPTOR CELLS; SODIUM; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SYNDROME;

EID: 70349932471     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79090-7_15     Document Type: Review

References (249)

1. Ahern CA, Eastwood AL, Dougherty DA, Horn RA (2008) Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels. Circ Res 102:86-94
2. Akada Y, Ogawa S, Amano K, Fukudome Y, Yamasaki F, Itoh M, Yamamoto I (2006) Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats. Eur J Pharmacol 536:248-255
3. Alpert LA, Fozzard HA, Hanck DA, Makielski JC (1989) Is there a second external lidocaine binding site on mammalian cardiac cells? Am J Physiol 257:H79-H84
4. Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, Gold MS, Porreca F, Strichartz GR (2006) The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain 7(Suppl 3):S1-S29
5. Anger T, Madge DJ, Mulla M, Riddall D (2001) Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem 44:115-137
6. Armstrong CM (1971) Interaction of tetraethyammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 58:413-437
7. Armstrong CM (2007) Na channel inactivation from open and closed states. Proc Natl Acad Sci USA 103:17991-17996
8. + current by local anaesthetics in rat large sensory neurones. Br J Pharmacol 129:1617-1626
9. + current in rat and mouse sensory neurones. J Physiol 567:851-867
10. Balser JR, Nuss HB, Romashko DN, Marban E, Tomaselli GF (1996) Functional consequences of lidocaine binding to slow-inactivated sodium channels. J Gen Physiol 107:643-658
11. Becker S, Prusak-Sochaczewski E, Zamponi G, Beck-Sickinger AG, Gordon RD, French RJ (1992) Action of derivatives of muconotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry 31:8229-8238
12. Benjamin ER, Pruthi F, Olanrewaju S, Ilyin VI, Crumley G, Kutlina E, Valenzano KJ, Woodward RM (2006) State-dependent compound inhibition of NaV1.2 sodium channels using the FLIPR Vm dye: on-target effects of diverse pharmacological agents. J Biomol Screen 11:29-39
13. + channels. Modification of block by alterations in the alpha-subunit III-IV interdomain. Circ Res 77:584-592
14. Binshtok AM, Bean BP, Wolff CJ (2007) Inhibition of nociceptors by entry of impermeant sodium channel blockers. Nature 449:607-610
15. Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, Waxman SG (1996) Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res Mol Brain Res 43:117-131
16. Black JA, Cummins TR, Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, Waxman SG (1999) Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol 82:2776-2785
17. Black JA, Renganathan M, Waxman SG (2002) Sodium channel NaV1.6 is expressed along nonmyelinated axons and it contributes to conduction. Brain Res Mol Brain Res 105:19-28
18. + channel blockers on somatosensory processing by rat dorsal horn neurones. Neuroreport 8:1549-1554
19. + current slow inactivation in adaptation of action potential firing in small-diameter dorsal root ganglion neurons. J Neurosci 23:10338-10350
20. Bosmans F, Tytgat J (2007) Voltage-gated sodium channel modulation by scorpion alpha-toxins. Toxicon 49:142-158
21. Bosmans F, Maertens C, Verdonck F, Tytgat J (2004) The poison dart frog's batrachotoxin modulates NaV1.8. FEBS Lett 577:245-248
22. + currents in rat dorsal root ganglion neurons. Eur J Anaesthesiol 15:80-88
23. + currents in rat sensory neurons. Anesthesiology 94:137-144
24. Brochu RM, Dick IE, Tarpley JW, McGowan E, Gunner D, Herrington J, Shao PP, Ok D, Li C, Parsons WH, Stump GL, Regan CP, Lynch Jr. JJ, Lyons KA, McManus OB, Clark S, Ali Z, Kaczorowski GJ, Martin WJ, Priest BT (2006) Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats. Mol Pharmacol 69:823-832
25. Caeser M, Seabrook GR, Kemp JA (1993) Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex. Br J Pharmacol 109:918-924
26. Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR (2000) Sodium channel NaV1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci USA 97:5616-5620
27. Cameron J, Flowers AE, Capra MF (1991) Electrophysiological studies on ciguatera poisoning in man (part II). J Neurol Sci 101:93-97
28. + channels in rat vagal afferent neurons. Toxicon 43:401-406
29. Campos FV, Chanda B, Beirão PS, Bezanilla F (2007) beta-Scorpion toxin modifies gating transitions in all four voltage sensors of the sodium channel. J Gen Physiol 130:257-268
30. + channels by protein kinase C and protein kinase A anchored to AKAP-15. Mol Cell Neurosci 21:63-80
31. + channels. J Neurophysiol 86:241-248
32. Cardenas CA, Cardenas CG, de Armandi AJ, Scroggs RS (2006) Carbamazepine interacts with a slow inactivation state of NaV1.8-like sodium channels. Neurosci Lett 408:129-134
33. Carroll I (2007) Intravenous lidocaine for neuropathic pain: diagnostic utility and therapeutic efficacy. Curr Pain Headache Rep 11:20-24
34. + channels: local anesthetics, antiarrhymics and anticonvulsants. Trends Pharmacol Sci 8:57-65
35. Catterall WA (1986) Voltage-dependent gating of sodium channels: correlating structure and function. Trends Neurosci 9:7-10
36. Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25
37. Catterall WA, Goldin AL, Waxman SG (2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57:397-409
38. Cestele S, Catterall WA (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82:883-892
39. Chabal C, Russell LC, Burchiel KJ (1989) The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 38:333-338
40. Chahine M, Ziane R, Vijayaragavan K, Okamura Y (2005) Regulation of Na v channels in sensory neurons. Trends Pharmacol Sci 26:496-502
41. Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB (2005) Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 4:CD003345
42. Chen H, Lu SQ, Leipold E, Gordon D, Hansel A, Heinemann SH (2002) Differential sensitivity of sodium channels from the central and peripheral nervous system to the scorpion toxins Lqh-2 and Lqh-3. Eur J Neurosci 16:767-770
43. + currents in rat dorsal root ganglion neurons. Neurosci Lett 390:66-71
44. + currents in primary afferent neurons. Peptides 27:2182-2192
45. + channel slow inactivation via cAMP-dependent protein kinase and protein kinase C. Neuron 49:409-420
46. Chen D, Reierstad S, Lin Z, Lu M, Brooks C, Li N, Innes J, Bulun SE (2007) Prostaglandin E2 induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH2- terminal kinase in adipose fibroblasts. Cancer Res 67:8914-8922
47. Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13(2):107-112
48. Chevrier P, Vijayaragavan K, Chahine M (2004) Differential modulation of NaV1.7 and NaV1.8 peripheral nerve sodium channels by the local anaesthetic lidocaine. Br J Pharmacol 142:576-584 (Pubitemid 38869872)
49. Choi JS, Soderlund DM (2006) Structure-activity relationships for the action of 11 pyrethroid insecticides on rat Nav 1.8 sodium channels expressed in Xenopus oocytes. Toxicol Appl Pharmacol 211:233-244
50. Choudhary G, Yotsu-Yamashita M, Shang L, Yasumoto T, Dudley Jr. SC (2003) Interactions of the C-11 hydroxyl of tetrodotoxin with the sodium channel outer vestibule. Biophys J 84:287-294
51. Conti F, Gheri A, Pusch M, Moran O (1996) Use dependence of tetrodotoxin block of sodium channels: a revival of the trapped-ion mechanism. Biophys J 71:1295-1312
52. Courtney KR (1975) Mechanism of frequency-dependent inhibition of sodium currents in from myelinated nerve by the lidocaine derivative GEA 968. J Pharm Exp Ther 195:225-236
53. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, Karbani G, Jafri H, Mannan J, Raashid Y, Al-Gazali L, Hamamy H, Valente EM, Gorman S, Williams R, McHale DP, Wood JN, Gribble FM, Woods CG (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894-898
54. Craig W (1887) Manual of materia medica and therapeutics, 5th edn. Livingstone, Edinburgh
55. Cummins TR, Waxman SG (1997) Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 17:3503-3514
56. Cummins TR, Sheets PL, Waxman SG (2007) The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain 131:243-257
57. De Col R, Messlinger K, Carr RW (2008) Conduction velocity is regulated by sodium channel inactivation in unmyelinated axons innervating the rat cranial meninges. J Physiol 586:1089-1103
58. Dekker LV, Daniels Z, Hick C, Elsegood K, Bowden S, Szestak T, Burley JR, Southan A, Cronk D, James IF (2005) Analysis of human NaV1.8 expressed in SH-SY5Y neuroblastoma cells. Eur J Pharmacol 528:52-58
59. DeToledo JC (2000) Lidocaine and seizures. Ther Drug Monit 22:320-322
60. Devor M (2006) Sodium channels and mechanisms of neuropathic pain. J Pain 7(Suppl 1):S3-S12
61. Dib-Hajj S, Black JA, Cummins TR, Waxman SG (2002) NaN/NaV1.9: a sodium channel with unique properties. Trends Neurosci 25:253-259
62. Dib-Hajj SD, Rush AM, Cummins TR, Hisama FM, Novella S, Tyrrell L, Marshall L, Waxman SG (2005) Gain-of-function mutation in NaV1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128:1847-1854
63. Dick IE, Brochu RM, Purohit Y, Kaczorowski GJ, Martin WJ, Priest BT (2007) Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 8:315-324
64. Docherty RJ, Farrag KJ (2006) The effect of dibutyryl cAMP on tetrodotoxin-sensitive and -resistant voltage-gated sodium currents in rat dorsal root ganglion neurons and the consequences for their sensitivity to lidocaine. Neuropharmacology 51:1047-1057
65. Docherty RJ, Charlesworth G, Farrag K, Bhattacharjee A, Costa S (2005) The use of the rat isolated vagus nerve for functional measurements of the effect of drugs in vitro. J Pharm Tox Methods 51:235-242
66. Dong XW, Jia Y, Lu SX, Zhou X, Cohen-Williams M, Hodgson R, Li H, Priestley T (2008) The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain. Psychopharmacology 195:559-568
67. Dunlop R, Davies RJ, Hockley J, Turner P (1988) Analgesic effects of oral flecainide. Lancet 331:420-421
68. Eisenberg E, River Y, Shifrin A, Krivoy N (2007) Antiepileptic drugs in the treatment of neuropathic pain. Drugs 67:1265-1289
69. Ekberg J, Adams DJ (2006) Neuronal voltage-gated sodium channel subtypes: key roles in inflammatory and neuropathic pain. Int J Biochem Cell Biol. 38:2005-2010
70. Ekberg J, Craik DJ, Adams DJ (2008) Conotoxin modulation of voltage-gated sodium channels. Int J Biochem Cell Biol 40(11):2363-2368. doi:10.1016/j. biocel.2007.08.017
71. England S, Bevan S, Docherty RJ (1996) PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 495:429-440
72. Farrag KJ, Costa SK, Docherty RJ (2002) Differential sensitivity to tetrodotoxin and lack of effect of prostaglandin E2 on the pharmacology and physiology of propagated action potentials. Br J Pharmacol 135:1449-1456
73. Farrag KJ, Bhattacharjee A, Docherty RJ (2008) A comparison of the effects of veratridine on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in isolated rat dorsal root ganglion neurons. Pflugers Arch 455:929-938
74. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, Waxman SG (1997) Sodium channel alpha-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Brain Res Mol Brain Res 45:71-82
75. Fitzgerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ (1999) cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol 516:433-446 (Pubitemid 29204448)
76. + channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J Cell Physiol 195:479-487
77. Frohnwieser B, Weigl L, SchreibmayerW(1995) Modulation of cardiac sodium channel isoform by cyclic AMP dependent protein kinase does not depend on phosphorylation of serine 1504 in the cytosolic loop interconnecting transmembrane domains III and IV. Pflugers Arch 430:751-753
78. + current in rat hippocampal neurons. Brain Res 920:27-31
79. Ghatapande AS, Sikdar SK (1997) Competition for binding between veratridine and KIFMK: an open channel blocking peptide of the RIIA sodium channel. J Membr Biol 160:177-182
80. + currents in rat sensory neurons in vitro. J Pharmacol Exp Ther 299:705-711
81. + current in nociceptors. Proc Natl Acad Sci USA 93:1108-1112
82. Gold MS, Levine JD, Correa AM (1998) Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 18:10345-10355
83. Goldberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, Fraser R, Young C, Hossain S, Pape T, Payne B, Radomski C, Donaldson G, Ives E, Cox J, Younghusband HB, Green R, Duff A, Boltshauser E, Grinspan GA, Dimon JH, Sibley BG, Andria G, Toscano E, Kerdraon J, Bowsher D, Pimstone SN, Samuels ME, Sherrington R, Hayden MR (2007) Loss-of-function mutations in the NaV1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 71:311-319
84. Goldin AL, Snutch T, Lubbert H, Dowsett A, Marshall J, Auld V, Downey W, Fritz LC, Lester HA, Dunn R (1986) Messenger RNA coding for only the alpha subunit of the rat brain Na channel is sufficient for expression of functional channels in Xenopus oocytes. Proc Natl Acad Sci USA 83:7503-7507
85. Goudet C, Chi C-W, Tytgat J (2002) An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. Toxicon 40:1239-1258
86. Gould III HJ, England JD, Liu ZP, Levinson SR (1998) Rapid sodium channel augmentation in response to inflammation induced by complete Freund's adjuvant. Brain Res 802:69-74
87. Gould III HJ, England JD, Soignier RD, Nolan P, Minor LD, Liu ZP, Levinson SR, Paul D (2004) Ibuprofen blocks changes in Nav 1.7 and NaV 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat. J Pain 5:270-280
88. Grant AO, Chandra R, Keller C, Carboni M, Starmer CF (2000) Block of wild-type and inactivation deficient sodium channels IFM/QQQ stably expressed in mammalian cells. Biophysical J 79:3019-3035
89. Guven M, Bozdemir H, Gunay I, Sarica Y, Kahraman I, Koc F (2006) The actions of lamotrigine and levetiracetam on the conduction properties of isolated rat sciatic nerve. Eur J Pharmacol 553:129-134
90. Guy HR, Seetharamulu P (1986) Molecular model of the action potential sodium channel. Proc Natl Acad Sci USA 83:508-512
91. Hartshorne RP, Catterall WA (1981) Purification of the saxitoxin receptor of the sodium channel from rat brain. Proc Natl Acad Sci USA 78:4620-4624
92. Hartshorne RP, Catterall WA (1984) The sodium channel from rat brain. Purification and subunit composition. J Biol Chem 259:1667-1675
93. Hartshorne RP, Messner DJ, Coppersmith JC, Catterall WA (1984) The saxitoxin receptor of the sodium channel from rat brain. Evidence for two nonidentical beta subunits. J Biol Chem 257:13888-13891
94. Heinemann SH, Terlau H, Imoto K (1992) Molecular basis for pharmacological differences between brain and cardiac sodium channels. Pflugers Arch 422:90-92
95. Hille B (1975) The receptor for tetrodotoxin and saxitoxin. A structural hypothesis. Biophys J 15:615-619
96. Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug receptor reaction. J Gen Physiol 69:497-515
97. Hille B (2001) Ion channels of excitable membranes, 3rd edn. Sinauer, Sunderland
98. Hui K, Lipkind G, Fozzard HA, French RJ (2002) Electrostatic and steric contributions to block of the skeletal muscle sodium channel by muconotoxin. J Gen Physiol 119:45-54 (Pubitemid 34074592)
99. Hunt LW, Frigas E, Butterfield JH, Kita H, Blomgren J, Dunnette SL, Offord KP, Gleich GJ (2004) Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 113:853-859
100. Ichimata M, Ikebe H, Yoshitake S, Hattori S, Iwasaka H, Noguchi T (2001a) Analgesic effects of flecainide on postherpetic neuralgia. Int J Clin Pharmacol Res 21:15-19
101. Ichimata M, Kitano T, Ikebe H, Iwasaka H, Noguchi T (2001b) Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats. Neuroreport 12:1869-1873
102. 2+ currents of acutely isolated adult rat nodose ganglion cells. J Neurophysiol 55:527-539
103. Ilyin VI, Pomonis JD, Whiteside GT, Harrison JE, Pearson MS, Mark L, Turchin PI, Gottshall S, Carter RB, Nguyen P, Hogenkamp DJ, Olanrewaju S, Benjamin E, Woodward RM (2006) Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy) phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states. J Pharmacol Exp Ther 318:1083-1093
104. Isom LL, De Jongh KS, Patton DE, Reber BF, Offord J, Charbonneau H, Walsh K, Goldin AL, Catterall WA (1992) Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science 256:839-842
105. Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, Scheuer T, Catterall WA (1995) Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83:433-442
106. Jarvis B, Coukell AJ (1998) Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 56:691-707
107. Jeglitsch G, Rein K, Baden DG, Adams DJ (1998) Brevetoxin-3 (PbTx-3) and its derivatives modulate single tetrodotoxin-sensitive sodium currents in rat sensory neurons. J Pharmacol Exp Ther 284:516-525
108. Jin X, Gereau RW 4th (2006) Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 26:246-255
109. Keizer DW, West PJ, Lee EF, Yoshikami D, Olivera BM, Bulaj G, Norton RS (2003) Structural basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin SmIIIA. J Biol Chem 278:46805-46813
110. Kerr NC, Gao Z, Holmes FE, Hobson SA, Hancox JC, Wynick D, James AF (2007) The sodium channel NaV1.5a is the predominant isoform expressed in adult mouse dorsal root ganglia and exhibits distinct inactivation properties from the full-length NaV1.5 channel. Mol Cell Neurosci 35:283-291
111. Kim CH, Oh Y, Chung JM, Chung K (2001) The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res Mol Brain Res 95, 153-161
112. Ko SH, Jochnowitz N, Lenkowski PW, Batts TW, Davis GC, Martin WJ, Brown ML, Patel MK (2006) Reversal of neuropathic pain by alpha-hydroxyphenylamide: a novel sodium channel antagonist. Neuropharmacology 50:865-873
113. + channels. Mol Pharmacol 54:712-721
114. Kuo CC, Bean BP (1994) Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol Pharmacol 46:716-725
115. + channels in rat hippocampal neurones. Br J Pharmacol 121:1231-1238
116. Kyle DJ, Ilyin VI (2006) Sodium channel blockers. J Med Chem 50:2583-2588
117. Lai HC, Jan LY (2006) The distribution and targeting of neuronal voltage-gated ion channels. Nat Rev Neurosci 7:548-562
118. Lai J, Porreca F, Hunter JC, Gold MS (2004) Voltage-gated sodium channels and hyperalgesia. Ann Rev Pharmacol Toxicol 44:371-397
119. Lampert A, Hains BC, Waxman SG (2006) Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury. Exp Brain Res 174:660-666
120. Lang DG, Wang CM, Cooper BR (1993) Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 266(2):829-835
121. Leffler A, Herzog RI, Dib-Hajj SD, Waxman SG, Cummins TR (2005) Pharmacological properties of neuronal TTX-resistant sodium channels and the role of a critical serine pore residue. Pflugers Arch 451:454-463
122. + channels. J Pharm Exp Ther 320:354-364
123. Leipold E, Hansel A, Olivera BM, Terlau H, Heinemann SH (2005) Molecular interaction of delta-conotoxins with voltage-gated sodium channels. FEBS Lett 579:3881-3884
124. Leipold E, Hansel A, Borges A, Heinemann SH (2006) Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3. Mol Pharmacol 70:340-347
125. Li M, West JW, Lai Y, Scheuer T, Catterall WA (1992) Functional modulation of brain sodium channels by cAMP-dependent phosphorylation. Neuron 8:1151-1159
126. Li HL, Hadid D, Ragsdale DS (2002) The batrachotoxin receptor on the voltage-gated sodium channel is guarded by the channel activation gate. Mol Pharmacol 61:905-912
127. + channels. J Biol Chem 278:8717-8724
128. Liberatore AM, Schulz J, Favre-Guilmard C, Pommier J, Lannoy J, Pawlowski E, Barthelemy MA, Huchet M, Auguet M, Chabrier PE, Bigg D (2007) Butyl 2-(4-[1.10-biphenyl]-4-yl-1Himidazol- 2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain. Bioorg Med Chem Lett 17:1746-1749
129. Lindia JA, Kohler MG, Martin WJ, Abbadie C (2005) Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Pain 117:145-153
130. Lim TKY, MacLeod BA, Ries CR, Schwartz SKW (2007) The quaternary lidocaine derivative, QX- 314, produces long-lasting local anesthesia in animal models in vivo. Anesthesiology 107:305-311
131. + channel. Biophys J 66:1-13
132. Lipkind GM, Fozzard HA (2005) Molecular modeling of local anesthetic drug binding by voltagegated sodium currents. Mol Pharmacol 68:1611-1622
133. Liu G, Yarov-Yarovoy V, Nobbs M, Clare JJ, Scheuer T, Catterall WA (2003) Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltagegated sodium channels. Neuropharmacology 44:413-422
134. Liu CJ, Priest BT, Bugianesi RM, Dulski PM, Felix JP, Dick IE, BrochuRM, Knaus H-G, Middleton RE, Kaczorowski GJ, Slaughter RS, Garcia ML, Kohler MG (2006) A high-capacity membrane potential FRET-based assay for NaV1.8 channels. Assay Drug Dev Technol 4:37-48
135. + channel. FEBS Lett 219:355-359
136. Lönnendonker U (1994) Use dependence of guanidinium toxins in frog myelinated nerve: evidence for features of native voltage-gated sodium channels. Prog Neurobiol 42:359-374
137. Maertens C, Cuypers E, Amininasab M, Jalali A, Vatanpour H, Tytgat J (2006) Potent modulation of the voltage-gated sodium channel NaV1.7 by OD1, a toxin from the scorpion Odonthobuthus doriae. Mol Pharmacol 70:405-414
138. Matsuki N, Quandt FN, Ten Eick RE, Yeh JZ (1984) Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther 228:523-530
139. Matsumoto S, Yoshida S, Ikeda M, Tanimoto T, Saiki C, Takeda M, Shima Y, Ohta H (2007) Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (NaV1.8) current in smalldiameter nodose ganglion neurones. Neuropharmacology 52:904-924
140. McLeane G (2007) Intravenous lidocaine: an outdated or underutilized treatment for pain. J Palliat Med 10:798-805
141. McNulty MM, Edgerton GB, Shah RD, Hanck DA, Fozzard HA, Lipkind GM (2007) Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels. J Physiol 581:741-755
142. Messner DJ, Catterall WA (1985) The sodium channel from rat brain. Separation and characterization of subunits. J Biol Chem 260:10597-10604
143. Middleton RE, Warren VA, Kraus RL, Hwang JC, Liu CJ, Dai G, Brochu RM, Kohler MG, Gao YD, Garsky VM, Bogusky MJ, Mehl JT, Cohen CJ, Smith MM (2002) Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry 41:14734-14747
144. Morgan K, Stevens EB, Shah B, Cox PJ, Dixon AK, Lee K, Pinnock RD, Hughes J, Richardson PJ, Mizuguchi K, Jackson AP (2000) Beta 3: an additional auxiliary subunit of the voltagesensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci USA 97:2308-2313
145. + channel alpha subunit by cAMPdependent protein kinase and phosphoprotein phosphatases. J Biol Chem 268:27355-27362
146. Nakamura S, Atsuta Y (2005) Effect of sodium channel blocker (mexiletine) on pathological ectopic firing pattern in a rat chronic constriction nerve injury model. J Orthop Sci 10:315-320
147. Narahashi T (1986) Toxins that modulate the sodium channel gating mechanism. Ann N Y Acad Sci 479:133-151
148. Narahashi T, Frazier DT, Moore JW (1972) Comparison of tertiary and quaternary amine local anesthetics in their ability to depress membrane ionic conductances. J Neurobiol 3:267-276
149. + channels. J Membr Biol 201:1-8
150. Noda M (1993) Structure and function of sodium channels. Ann N Y Acad Sci 707:20-37
151. + channel beta 1 subunit mRNA: differential expression in rat spinal sensory neurons. Brain Res Mol Brain Res 30:357-361
152. O'Reilly AO, Khambay BP, Williamson MS, Field LM, Wallace BA, Davies TG (2006) Modelling insecticide-binding sites in the voltage-gated sodium channel. Biochem J 396:255-263
153. + currents in rat sensory neurons. Anesth Analg 99:464-471
154. + current and enhanced nociceptor excitability require NaV1.9. J Physiol 586:1077-1087
155. Padilla F, Couble ML, Coste B, Maingret F, Clerc N, Crest M, Ritter AM, Magloire H, Delmas P (2007) Expression and localization of the NaV1.9 sodium channel in enteric neurons and in trigeminal sensory endings: implication for intestinal reflex function and orofacial pain. Mol Cell Neurosci 35:138-152
156. Patton DE, Goldin AL (1991) A voltage-dependent gating transition induces use-dependent block by tetrodotoxin of rat IIA sodium channels expressed in Xenopus oocytes. Neuron 7:637-647
157. Pearn J (2001) Neurology of ciguatera. J Neurol Neurosurg Psychiatr 70:4-8
158. Pratt CM, Moye LA (1990) The cardiac arrhythmia suppression trial: background, interim results and implications. Am J Cardiol 65:20B-29B
159. Priest BT, Blumenthal KM, Smith JJ, Warren VA, SmithMM(2007) ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels. Toxicon 49:194-201
160. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol Pharmacol 40:756-765
161. + channels by local anaesthetics. Science 265:1724-1728
162. + channels. Proc Natl Acad Sci USA 93:9270-9275
163. Ratcliffe CF, Westenbroek RE, Curtis R, Catterall WA (2001) Sodium channel beta1 and beta3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J Cell Biol 154:427-434
164. Renganathan M, Cummins TR, Waxman SG (2001) Contribution of NaV1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 86:629-640
165. Renganathan M, Dib-Hajj S, Waxman SG (2002) NaV1.5 underlies the 'third TTX-R sodium current' in rat small DRG neurons. Brain Res Mol Brain Res 106:70-82
166. Ritter AM, Ritchie C, Martin WJ (2007) Relationship between the firing frequency of injured peripheral neurons and inhibition of firing by sodium channel blockers. J Pain 8:287-295
167. Rogawski MA, Löscher W (2004) The neurobiology of antiepileptic
168. Roy ML, Narahashi T (1992) Differential properties of tetrodotoxin-sensitive and tetrodotoxinresistant sodium channels in rat dorsal root ganglion neurons. J Neurosci 12:2104-2111
169. Rush AM, Elliott JR (1997) Phenytoin and carbamazepine: differential inhibition of sodium currents in small cells from adult rat dorsal root ganglia. Neurosci Lett 226:95-98
170. Rush AM, Dib-Hajj SD, Waxman SG (2005) Electrophysiological properties of two axonal sodium channels, NaV1.2 and NaV1.6, expressed in mouse spinal sensory neurones. J Physiol 564:803-815
171. Rush AM, Cummins TR, Waxman SG (2007) Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol 579:1-14
172. Saab CY, Cummins TR, Dib-Hajj SD, Waxman SG (2002) Molecular determinant of NaV1.8 sodium channel resistance to the venom from the scorpion Leiurus quinquestraitus hebraeus. Neurosci Lett 331:79-82
173. Salgado VL, Yeh JZ, Narahashi T (1986) Use- and voltage-dependent block of the sodium channel by saxitoxin. Ann N Y Acad Sci 479:84-95
174. + channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access. Mol Pharmacol 66:330-336
175. Satin J, Kyle JW, Chen M, Bell P, Cribbs LL, Fozzard HA, Rogart RB (1992) A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science 256:1202-1205
176. Sato K, Ishida Y, Wakamatsu K, Kato R, Honda H, Ohizumi Y, Nakamura H, Ohya M, Lancelin JM, Kohda D, Inagaki F (1991) Active site of mu-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem 266:16989-16991
177. Scheib H,McLay I, Guex N, Clare JJ, Blaney FE, Dale TJ, Tate SN, RobertsonGM(2006)Modelling the pore structure of voltage-gated sodium channels in closed, open, and fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding. J Mol Model 12:813-822
178. + currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons. J Neurophysiol 79:1746-1754
179. Schwarz JR, Grigat G (1989) Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers. Epilepsia 30:286-294
180. Schneider M, Datta S, Strichartz G (1991) A preferential inhibition of impulses in C-fibers of the rabbit vagus nerve by veratridine, an activator of sodium channels. Anaesthesiology 74:270-280
181. Segal MM, Douglas AF (1997) Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol 77:3021-3034
182. Shah BS, Stevens EB, Gonzalez MI, Bramwell S, Pinnock RD, Lee K, Dixon AK (2000) Beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain. Eur J Neurosci 12:3985-3990
183. Shao PP, Ok D, Fisher MH, Garcia ML, Kaczorowski GJ, Li C, Lyons KA, Martin WJ, Meinke PT, Priest BT, Smith MM, Wyvratt MJ, Ye F, Parsons WH (2005) Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain. Bioorg Med Chem Lett 15:1901-1907
184. Sheets MF, Hanck DA (2007) Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels. J Physiol 582:317-334
185. Shon KJ, Olivera BM, Watkins M, Jacobsen RB, Gray WR, Floresca CZ, Cruz LJ, Hillyard DR, Brink A, Terlau H, Yoshikami D (1998) mu-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J Neurosci 18:4473-4481
186. Sivilotti L, Okuse K, Akopian AN, Moss S, Wood JN (1997) A single serine residue confers tetrodotoxin insensitivity on the rat sensory-neuron-specific sodium channel SNS. FEBS Lett 409:49-52
187. Smith KJ (2007) Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol 17:230-242
188. Smith RD, Goldin AL (1996) Phosphorylation of brain sodium channels in the I-II linker modulates channel function in Xenopus oocytes. J Neurosci 16:1965-1974
189. Smith RD, Goldin AL (1998) Functional analysis of the rat I sodium channel in Xenopus oocytes. J Neurosci 18:811-820
190. Smith RD, Goldin AL (2000) Potentiation of rat brain sodium channel currents by PKA in Xenopus oocytes involves the I-II linker. Am J Physiol Cell Physiol 278:C638-C645
191. Smith JJ, Cummins TR, Alphy S, Blumenthal KM (2007) Molecular interactions of the gating modifier toxin ProTx-II with NaV1.5: implied existence of a novel toxin binding site coupled to activation. J Biol Chem 282:12687-12697
192. Song JH, Nagata K, Huang CS, Yeh JZ, Narahashi T (1996) Differential block of two types of sodium channels by anticonvulsants. Neuroreport 7:3031-3036
193. Spina E, Perugi G (2004) Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 6:57-75
194. Srinivasan J, Schachner M, Catterall WA (1998) Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci USA 95:15753-15757
195. Ständker L, Béress L, Garateix A, Christ T, Ravens U, Salceda E, Soto E, John H, Forssmann WG, Aneiros A (2006) A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon 48:211-220
196. Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 46:15-27
197. Stephan MM, Potts JF, Agnew WS (1994) The microI skeletal muscle sodium channel: mutation E403Q eliminates sensitivity to tetrodotoxin but not to mu-conotoxins GIIIA and GIIIB. J Membr Biol 137:1-8
198. Strachan LC, Lewis RJ, Nicholson GM (1999) Differential actions of pacific ciguatoxin-1 on sodium channel subtypes in mammalian sensory neurons. J Pharmacol Exp Ther 288:379-388
199. Strichartz GR (1973) The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol 62:37-57
200. + currents in dorsal root ganglion neurons. Eur J Pharmacol 510:197-208
201. Su X, Riedel ES, Leon LA, Laping NJ (2007) Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension. Neurourol Urodyn 27:249-253
202. Sugai K (2007) Treatment of convulsive status epilepticus in infants and young children in Japan. Acta Neurol Scand Suppl 186:62-70
203. Sun GC, Werkman TR, Battefeld A, Clare JJ, Wadman WJ (2007) Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the NaV1.3 alpha-subunit. Epilepsia 48:774-782
204. Sunami A, Glasser IW, Fozzard HA (2000) A critical residue for isoforms difference in tetrodotoxin affinity is a molecular determinant of the external path for local anesthetics in the cardiac sodium channel. Proc Nat Acad Sci USA 97:2326-2331
205. Szallasi A, Cruz F, Geppetti P (2006) TRPV1: a therapeutic target for novel analgesic drugs? Tr Mol Med 12:545-554
206. Tabarean IV, Narahashi T (2001) Kinetics of modulation of tetrodotoxin-sensitive and tetrodotoxinresistant sodium channels by tetramethrin and deltamethrin. J Pharm Exp Ther 299:988-997
207. + currents in dorsal root ganglion neurons. Neurosci Lett 297:65-68
208. + channels in rat sensory neurons. Eur J Anaesthesiol 24:782-788
209. Tatebayashi H, Narahashi T (1994) Differential mechanism of action of the pyrethroid tetramethrin on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 270:595-603
210. + current in neocortical neurons. Epilepsy Res 32:304-308
211. Terlau H, Heinemann SH, Stuhmer W, Pusch M, Conti F, Imoto K, Numa S (1991) Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett 293:93-96
212. Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V (2003) Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 140:255-260
213. Toledo-Aral JJ, Moss BL, He ZJ, Koszowski AG, Whisenand T, Levinson SR, Wolf JJ, Silos-Santiago I, Halegoua S, Mandel G (1997) Identification of PN1, a predominant voltagedependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 94:1527-1532
214. Trainer VL, Baden DG, Catterall WA (1994) Identification of peptide components of the brevetoxin receptor site of rat brain sodium channels. J Biol Chem 269:19904-19909
215. Tzeng JI, Cheng KI, Huang KL, Chen YW, Chu KS, Chu CC, Wang JJ (2007) The cutaneous analgesic effect of class I antiarrhythmic drugs. Anesth Analg 104:955-958
216. Ulbricht W (1998) Effects of veratridine on sodium currents and fluxes. Rev Physiol Biochem Pharmacol 133:1-54
217. + channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain 102:17-25
218. Vickery RG, Amagasu SM, Chang R, Mai N, Kauman E, Martin J, Hembrador J, O'Keefe MD, Gee C, Marquess D, Smith JA (2004) Comparison of the pharmacological properties of rat NaV1.8 with Rat NaV 1.2a and human NaV1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR. Receptors Channels 10:11-23
219. Vijayaragavan K, Boutjdir M, Chahine M (2004) Modulation of NaV1.7 and NaV1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C. J Neurophysiol 91: 1556-1569
220. Von Gunten CF, Eappen S, Cleary JF, Taylor SG 4th, Moots P, Regevik N, Cleeland C, Cella D (2007) Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med 21:667-672
221. Wang S-Y, Wang GK (2003) Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 15:151-159
222. Wang GK, Brodwick MS, Eaton DC, Strichartz GR (1987) Inhibition of sodium currents by local anaesthetics in chloramine-T treated squid axons. The role of channel activation. J Gen Physiol 89:645-667
223. + channels by local anaesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway. J Gen Physiol 124:691-701
224. Wang CZ, Zhang H, Jiang H, Lu W, Zhao ZQ, Chi CW (2006) A novel conotoxin from Conus striatus, mu-SIIIA, selectively blocking rat tetrodotoxin-resistant sodium channels. Toxicon 47:122-132
225. + channel. Pflugers Arch 454: 277-287
226. Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7:932-941
227. Waxman SG, Kocsis JD, Black JA (1994) Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is re-expressed following axotomy. J Neurophysiol 72:466-470
228. + currents in rat sensory neurons and recombinant NaV1.2 channels. Neurosci Lett 395:179-184
229. +-channel inactivation. Proc Natl Acad Sci USA 89:10910-10914
230. Wiffen PJ, Rees J (2007) Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2: CD006044
231. Williams BS, Felix JP, Priest BT, Brochu RM, Dai K, Hoyt SB, London C, Tang YS, Duffy JL, Parsons WH, Kaczorowski GJ, Garcia ML (2007) Characterization of a new class of potent inhibitors of the voltage-gated sodium channel NaV1.7. Biochemistry 46:14693-14703
232. Willow M, Catterall WA (1982) Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 22:627-635
233. Willow M, Gonoi T, Catterall WA (1985) Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol Pharmacol 27:549-558
234. Wittmack EK, Rush AM, Hudmon A, Waxman SG, Dib-Hajj SD (2005) Voltage-gated sodium channel NaV1.6 is modulated by p38 mitogen-activated protein kinase. J Neurosci 25:6621-6630
235. Wood JN, Boorman JP, Okuse K, Baker MD (2004) Voltage-gated sodium channels and pain pathways. J Neurobiol 61:55-71
236. + ions. J Physiol 538:759-771
237. Xiao Y, Tang J, Hu W, Xie J, Maertens C, Tytgat J, Liang S (2005) Jingzhaotoxin-I, a novel spider neurotoxin preferentially inhibiting cardiac sodium channel inactivation. J Biol Chem 280:12069-12076
238. Yakehiro M, Yuki T, Yamaoka K, Furue T, Mori Y, Imoto K, Seyama I (2000) An analysis of the variations in potency of gryanotoxin analogs in modifying frog sodium channels of different subtypes. Mol Pharmacol 58:692-700
239. + channel blocker, on firing properties of nociceptive dorsal root ganglion neurons of adult rats. Exp Neurol 208:63-72
240. + channel alpha subunit. J Biol Chem 276:20-27
241. + channel alpha subunit in voltage-dependent gating and drug block. J Med Chem 277:35393-35401
242. Ye JG, Wang CY, Li YJ, Tan ZY, Yan YP, Li C, Chen J, Ji YH (2000) Purification, cDNA cloning and function assessment of BmK abT, a unique component from the Old World scorpion species. FEBS Lett 479:136-140
243. Yu FH, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4:207
244. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, Ferriera H, Lilly J, DiStefano PS, Catterall WA, Scheuer T, Curtis R (2003) Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 23:7577-7585
245. Zhang MM, Green BR, Catlin P, Fiedler B, Azam L, Chadwick A, Terlau H, McArthur JR, French RJ, Gulyas J, Rivier JE, Smith BJ, Norton RS, Olivera BM, Yoshikami D, Bulaj G (2007) Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels. J Biol Chem 282:30699-30706
246. Zhou X, Dong XW, Crona J, Maguire M, Priestley T (2003) Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 306:498-504
247. Zhou X, Dong XW, Priestley T (2006) The neuroleptic drug, fluphenazine, blocks neuronal voltage-gated sodium channels. Brain Res 1106:72-81
248. Zimmermann K, Leffler A, Babes A, Cendan CM, Carr RW, Kobayashi J, Nau C, Wood JN, Reeh PW (2007) Sensory neuron sodium channel NaV1.8 is essential for pain at low temperatures. Nature 447:855-858 (Pubitemid 46920141)
249. Zlotkin E (1999) The insect voltage-gated sodium channel as target of insecticides. Annu Rev Entemol 44:429-455 (Pubitemid 29096979)